AVITA Medical, Inc. / Fundamentals
Income statement
- Net revenue
€50.52M - Cost of goods sold
€9.50M - Gross profit
€49.31M - SG&A expenses
€63.23M - R&D expenses
€22.55M - EBITDA
-€46.11M - D&A
€1.62M - EBIT
-€46.85M - Interest expenses
€0.00 - EBT
-€43.48M - Tax expenses
€100.18K - Net income
-€43.58M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
€961.82K - Changes in working capital
-€7.43M - Operating cash flow
-€39.68M - Capex
€1.51M - Other investing cash flow
€74.34M - Net investing cash flow
€72.83M - Total cash dividends paid
€0.00 - Issuance of common stock
€0.00 - Debt repayment
€0.00 - Other financing cash flow
€2.37M - Net financing cash flow
€2.37M - Foreign exchange effects
€35.29K - Net change in cash
€35.93M - Cash at end of period
€67.88M - Free cash flow
-€38.17M
Balance sheet
- Cash and cash equivalents
€67.88M - Cash and short-term investments
€80.24M - Total receivables
€8.11M - Inventory
€5.84M - Other current assets
€4.48M - Total current assets
€98.67M - Property, plant & equipment
€5.96M - Goodwill
€0.00 - Intangible assets
€612.63K - Long-term investments
€0.00 - Other non-current assets
€2.88M - Total non-current assets
€9.46M - Total assets
€108.13M - Accounts payable
€4.03M - Short-term debt
€775.63K - Other current liabilities
€7.74M - Total current liabilities
€15.80M - Long-term debt
€2.46M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€5.81M - Total non-current liabilities
€8.28M - Total liabilities
€24.07M - Common stock
€4.00K - Retained earnings
-€388.27M - Other equity
€8.93M - Total equity
€84.06M - Total liabilities and shareholders' equity
€108.13M
Company information
- Market capitalization
€122.74M - Employees
260 - Enterprise Value
€192.13M
Company ratios
- Gross margin
-
97.6% Much better than peer group: -35.2% - EBITDA margin
-
-91.3% Much better than peer group: -284.2% - EBIT margin
-
-92.7% Much better than peer group: -296.8% - EBT margin
-
-86.1% Much better than peer group: -334.6% - Net margin
-
-86.3% Much better than peer group: -289.4% - ROE
-
-51.9% Much worse than peer group: 34.3% - ROA
-
-40.3% Worse than peer group: -29.5% - Asset turnover
-
46.7% Worse than peer group: 65.9% - FCF margin
-
-81.5% Much better than peer group: -275.6% - FCF yield
-33.6% - Efficiency ratio
191.3% - Net sales per employee
-
€194.29K - Net income per employee
-
-€167.63K